Tao Dai

发表论文 46 篇 · 总被引 176 次 · h-index 3

代表论文

OA03.06 CodeBreaK 100/101: First Report of Safety/Efficacy of Sotorasib in Combination with Pembrolizumab or Atezolizumab in Advanced KRAS p.G12C NSCLC (2022 · Journal of Thoracic Oncology · 被引 109)
OA03.03 Sotorasib in Combination with RMC-4630, a SHP2 Inhibitor, in KRAS p.G12C-Mutated NSCLC and Other Solid Tumors (2022 · Journal of Thoracic Oncology · 被引 55)
FBXO24 Suppresses Breast Cancer Tumorigenesis by Targeting LSD1 for Ubiquitination (2023 · Molecular Cancer Research · 被引 12)
Supplementary Figure 1 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination (2024)
Supplementary Figure 2 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination (2024)
Table S1 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination (2024)